These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

319 related items for PubMed ID: 17156137

  • 1. Efficacy of tegaserod in chronic constipation in men.
    Fried M, Johanson JF, Gwee KA, Wagner A, Pecher E, Rueegg P.
    Am J Gastroenterol; 2007 Feb; 102(2):362-70. PubMed ID: 17156137
    [Abstract] [Full Text] [Related]

  • 2. Tegaserod for the treatment of chronic constipation: a randomized, double-blind, placebo-controlled multinational study.
    Kamm MA, Müller-Lissner S, Talley NJ, Tack J, Boeckxstaens G, Minushkin ON, Kalinin A, Dzieniszewski J, Haeck P, Fordham F, Hugot-Cournez S, Nault B.
    Am J Gastroenterol; 2005 Feb; 100(2):362-72. PubMed ID: 15667494
    [Abstract] [Full Text] [Related]

  • 3. Safety and tolerability of tegaserod in patients with chronic constipation: pooled data from two phase III studies.
    Quigley EM, Wald A, Fidelholtz J, Boivin M, Pecher E, Earnest D.
    Clin Gastroenterol Hepatol; 2006 May; 4(5):605-13. PubMed ID: 16678076
    [Abstract] [Full Text] [Related]

  • 4. Review article: tegaserod for chronic constipation.
    Johanson JF.
    Aliment Pharmacol Ther; 2004 Nov; 20 Suppl 7():20-4. PubMed ID: 15521851
    [Abstract] [Full Text] [Related]

  • 5. Tegaserod for female patients suffering from IBS with mixed bowel habits or constipation: a randomized controlled trial.
    Chey WD, Paré P, Viegas A, Ligozio G, Shetzline MA.
    Am J Gastroenterol; 2008 May; 103(5):1217-25. PubMed ID: 18477346
    [Abstract] [Full Text] [Related]

  • 6. Clinical trial: the efficacy, impact on quality of life, and safety and tolerability of prucalopride in severe chronic constipation--a 12-week, randomized, double-blind, placebo-controlled study.
    Quigley EM, Vandeplassche L, Kerstens R, Ausma J.
    Aliment Pharmacol Ther; 2009 Feb 01; 29(3):315-28. PubMed ID: 19035970
    [Abstract] [Full Text] [Related]

  • 7. A randomized, multicenter comparison of polyethylene glycol laxative and tegaserod in treatment of patients with chronic constipation.
    Di Palma JA, Cleveland MV, McGowan J, Herrera JL.
    Am J Gastroenterol; 2007 Sep 01; 102(9):1964-71. PubMed ID: 17573794
    [Abstract] [Full Text] [Related]

  • 8. A randomized, multicenter, placebo-controlled trial of polyethylene glycol laxative for chronic treatment of chronic constipation.
    Dipalma JA, Cleveland MV, McGowan J, Herrera JL.
    Am J Gastroenterol; 2007 Jul 01; 102(7):1436-41. PubMed ID: 17403074
    [Abstract] [Full Text] [Related]

  • 9. Effect of tegaserod on work and daily activity in irritable bowel syndrome with constipation.
    Reilly MC, Barghout V, McBurney CR, Niecko TE.
    Aliment Pharmacol Ther; 2005 Sep 01; 22(5):373-80. PubMed ID: 16128674
    [Abstract] [Full Text] [Related]

  • 10. Efficacy of tegaserod for functional constipation in Chinese subjects: a randomized double-blind controlled trial in a single centre.
    On Chan AO, Mo Hui W, Leung G, Hu WH, Lam SK, Wong BC.
    Aliment Pharmacol Ther; 2007 Feb 15; 25(4):463-9. PubMed ID: 17270002
    [Abstract] [Full Text] [Related]

  • 11. Safety, tolerability, and efficacy of tegaserod over 13 months in patients with chronic constipation.
    Müller-Lissner S, Kamm MA, Musoglu A, Earnest DL, Dunger-Baldauf C, Shetzline MA.
    Am J Gastroenterol; 2006 Nov 15; 101(11):2558-69; quiz 2671. PubMed ID: 17090282
    [Abstract] [Full Text] [Related]

  • 12. A randomised controlled trial assessing the efficacy and safety of repeated tegaserod therapy in women with irritable bowel syndrome with constipation.
    Tack J, Müller-Lissner S, Bytzer P, Corinaldesi R, Chang L, Viegas A, Schnekenbuehl S, Dunger-Baldauf C, Rueegg P.
    Gut; 2005 Dec 15; 54(12):1707-13. PubMed ID: 16020489
    [Abstract] [Full Text] [Related]

  • 13. Efficacy of linaclotide for patients with chronic constipation.
    Lembo AJ, Kurtz CB, Macdougall JE, Lavins BJ, Currie MG, Fitch DA, Jeglinski BI, Johnston JM.
    Gastroenterology; 2010 Mar 15; 138(3):886-95.e1. PubMed ID: 20045700
    [Abstract] [Full Text] [Related]

  • 14. A randomized, double-blind, placebo-controlled trial assessing the efficacy and safety of tegaserod in patients from China with chronic constipation.
    Lin SR, Ke MY, Luo JY, Yuan YZ, Wang JY, diTommaso S, Walter V, Huang J.
    World J Gastroenterol; 2007 Feb 07; 13(5):732-9. PubMed ID: 17278196
    [Abstract] [Full Text] [Related]

  • 15. Multicenter, 4-week, double-blind, randomized, placebo-controlled trial of sodium picosulfate in patients with chronic constipation.
    Mueller-Lissner S, Kamm MA, Wald A, Hinkel U, Koehler U, Richter E, Bubeck J.
    Am J Gastroenterol; 2010 Apr 07; 105(4):897-903. PubMed ID: 20179697
    [Abstract] [Full Text] [Related]

  • 16. Effect of tegaserod on colonic transit time in male patients with constipation-predominant irritable bowel syndrome.
    Harish K, Hazeena K, Thomas V, Kumar S, Jose T, Narayanan P.
    J Gastroenterol Hepatol; 2007 Aug 07; 22(8):1183-9. PubMed ID: 17688659
    [Abstract] [Full Text] [Related]

  • 17. Tegaserod for treating chronic constipation in elderly patients.
    Baun RF, Levy HB.
    Ann Pharmacother; 2007 Feb 07; 41(2):309-13. PubMed ID: 17227825
    [Abstract] [Full Text] [Related]

  • 18. Safety and tolerability of tegaserod in patients with irritable bowel syndrome and diarrhea symptoms.
    Fidelholtz J, Smith W, Rawls J, Shi Y, Zack A, Rüegg P, Lefkowitz M.
    Am J Gastroenterol; 2002 May 07; 97(5):1176-81. PubMed ID: 12014724
    [Abstract] [Full Text] [Related]

  • 19. [A randomized, double-blind, placebo-controlled, multicenter study to assess the efficacy and safety of tegaserod in Chinese patients with constipation-predominant irritable bowel syndrome].
    Tegaserod Clinical Research Group.
    Zhonghua Nei Ke Za Zhi; 2003 Feb 07; 42(2):88-90. PubMed ID: 12783702
    [Abstract] [Full Text] [Related]

  • 20. Tegaserod is effective in the initial and retreatment of irritable bowel syndrome with constipation.
    Müller-Lissner S, Holtmann G, Rueegg P, Weidinger G, Löffler H.
    Aliment Pharmacol Ther; 2005 Jan 01; 21(1):11-20. PubMed ID: 15644040
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.